INIS
patients
100%
sensitivity
47%
myocardial infarction
46%
concentration
41%
diseases
34%
levels
31%
drugs
29%
risks
27%
blood
26%
kidneys
24%
comparative evaluations
24%
biological markers
22%
values
21%
reviews
20%
cytochromes
20%
populations
20%
coronaries
20%
humans
18%
interstitials
17%
genetics
16%
lungs
15%
lipids
15%
data
14%
performance
14%
toxicity
14%
plasma
13%
injuries
12%
proteins
12%
variations
12%
sampling
12%
metabolism
11%
control
11%
genotype
11%
liver
11%
design
11%
sex
11%
bypasses
10%
mortality
10%
genes
10%
arteries
10%
prediction
10%
women
10%
transplants
10%
stratification
10%
receptors
10%
surgery
10%
laboratories
9%
filtration
9%
vitamin k
9%
doses
9%
Keyphrases
Cardiac Troponin
55%
High-sensitivity Cardiac Troponin
37%
Maastricht
32%
Polymorphism
24%
Hs-cTnT
23%
Acute Myocardial Infarction
15%
Sarcoidosis
13%
Variant Allele
12%
Tacrolimus
12%
Troponin
11%
Pharmacogenetics
11%
Drug-induced Interstitial Lung Disease
11%
Acute Myocardial Infarction Diagnosis
10%
CYP3A5
10%
Meta-analysis
10%
Cytochrome P450 Enzymes
9%
Risk Stratification
8%
Myocardial Infarction
8%
CYP2C9
8%
Coronary Artery Bypass Grafting
8%
Cardiac Injury
8%
Cytochrome P450 Polymorphisms
8%
Vitamin K Epoxide Reductase
8%
CTnI
7%
Oxyphytosterols
7%
Cognitive Performance
7%
Genetic Polymorphism
7%
Aging Studies
7%
High Sensitivity
7%
Idiopathic Pulmonary Fibrosis
7%
CYP2C19
7%
Cytochrome
7%
ST-elevation Myocardial Infarction (STEMI)
6%
Confidence Interval
6%
Estimated Glomerular Filtration Rate
6%
Cardiac Biomarkers
6%
Vitamin E
6%
Clinical Practice
5%
Tumor Necrosis Factor-α
5%
Allelic Variants
5%
Sex-specific
5%
Hepatic Fat
5%
Lipid Metabolism
5%
Type 2 Diabetes Mellitus (T2DM)
5%
Mass Spectrometry
5%
Pulmonary Sarcoidosis
5%
Mass Spectrometry Imaging
5%
Nitric Oxide
5%
Restricted Sampling
5%
Cytochrome P450 2D6 (CYP2D6)
5%
Medicine and Dentistry
Cardiac Troponin
31%
Troponin T
22%
Troponin I
11%
Biological Marker
10%
Meta-Analysis
10%
Allele
9%
Risk Stratification
9%
Myocardial Infarction
8%
Coronary Artery Bypass Graft
8%
Systematic Review
7%
Sarcoidosis
7%
Cardiovascular Disease
6%
Hemodialysis
6%
Diagnosis
6%
Cytochrome P450 3A5
5%
Pulmonary Hemorrhage
5%
Cohort Analysis
5%
Lipid Metabolism
5%
CYP2C9
5%
Vitamin K Epoxide Reductase
5%
First Trimester Pregnancy
5%
Kidney Graft
5%
Genotype
5%
Heart Injury
5%
Randomized Controlled Trial
5%
Tacrolimus
5%
Chorioamnionitis
5%
Nitric Oxide
5%
Genetic Polymorphism
5%
Lung Injury
5%
Cohort Effect
5%
Small for Gestational Age
5%
Coronary Vein
5%
Non ST Segment Elevation Myocardial Infarction
5%
Fetus Growth
5%
Maturity Onset Diabetes of the Young
5%
